- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
JP Morgan and Houlihan Lokey have emerged as the top mergers and acquisitions (M&A) financial advisers by value and volume globally during the first half (H1) of 2024 in the latest Financial Advisers League Table by GlobalData, a leading data and analytics company. An analysis of GlobalData’s Deals Database has revealed that JP Morgan achieved […]
Global efforts intensify to curb gas flaring amid environmental concerns, finds GlobalData
The oil and gas industry has been under increased scrutiny in recent years for its flaring of associated gases produced during crude oil extraction. While global flaring volumes have steadily declined, the top five gas-flaring countries (Russia, Iran, Iraq, Algeria, and Venezuela) have seen little change in their flaring levels. The industry is collaborating with […]
US-China tech dynamics shine light on thriving underwater drone investments, notes GlobalData
In a race to strengthen underwater capabilities, the US and China are accelerating efforts in advanced technologies such as the Manta Ray underwater drone, highlighting their strategic significance. The recent developments highlight the critical role of underwater drones in military, environmental, and infrastructure applications. With significant investments driving innovation in endurance, navigation, and data collection […]
Diagnosed prevalent cases of chronic kidney disease to reach 22.97 million across 7MM in 2033, predicts GlobalData
The diagnosed prevalent cases of chronic kidney disease (CKD) across the seven major markets (*7MM) are projected to increase at an annual growth rate (AGR) of 0.90% from 21.08 million in 2023 to 22.97 million in 2033, forecasts GlobalData, a leading data and analytics company. GlobalData’s latest report, “Chronic Kidney Disease: Epidemiology Forecast to 2033,” […]
Payment cards account for over half of e-commerce payments in US, reveals GlobalData
Payment cards are the preferred payment method for e-commerce purchases in the US, collectively accounting for 56.3% share in 2023, finds the 2023 Financial Services Consumer Survey* conducted by GlobalData, a leading data and analytics company. GlobalData’s E-Commerce Analytics reveal that e-commerce market in the US grew by 9.8% in 2023 to reach $2 trillion, […]
GenAI to revolutionize financial services with enhanced decision-making and personalization, says GlobalData
Generative AI (genAI) is set to transform financial services across banking, insurance, and wealth management. This technology is advancing through distinct phases, offering transformative capabilities such as enhanced decision-making, personalized services, and innovative product development. With significant funding growth and increasing adoption, genAI is set to drive unprecedented innovation and operational efficiency in the industry, […]
AI and robotics unlock sustainable efficiency in oil and gas sector, says GlobalData
Artificial intelligence (AI) and robotics are leading the transformative changes in the oil and gas sector, accelerating advancements in operational efficiency, safety, and environmental sustainability. These technologies are reshaping how the sector approaches exploration, production, refining, and logistics, instituting a new era of innovations for heightened productivity, efficiency, sustainability, and safety, according to GlobalData, a […]
Ajovy benefits diminish with migraine treatment cessation and re-initiation, says GlobalData
The interim results from the observational, prospective Phase IV Pan-European Real-Life (PEARL) study, presented at the 10th Congress of the European Academy of Neurology, indicate that treatment cessation and re-initiation can reduce the benefits of Teva Pharmaceutical’s Ajovy for migraine management. Continuous administration of Ajovy is crucial for effective prevention, challenging current guidelines that recommend […]
VNS and cenobamate combo therapy success paves way for cenobamate monotherapy, says GlobalData
At the recently held 10th Congress of the European Academy of Neurology (EAN), two investigator-led ePresentation sessions on epilepsy outlined the effectiveness of a combination of a new anti-seizure medication (ASM), Xcopri (cenobamate) and vagus nerve stimulation (VNS) in managing drug-resistant epilepsy (DRE). The combination therapy demonstrated significant improvements in seizure control, highlighting its potential […]
Labour Party victory signals new dawn for government transformation in the UK, says GlobalData
The overwhelming victory for the Labour Party in the UK general election provides a platform to reinvigorate digital transformation of public services. The mission-led government promised by incoming Prime Minister Sir Keir Starmer should open up opportunities to exploit the rich seam of data held by the government to deliver better outcomes for citizens, says […]
Leqvio and Repatha to spearhead lipid-modifying agents market resurgence, says GlobalData
The lipid-modifying agents market, which had seen a dramatic decline over the past decade, is now set for a spectacular revival, driven by the innovating therapies Leqvio (inclisiran) from Novartis and Repatha (evolocumab) from Amgen. These two treatments are forecast to spreadhead the market’s resurgence, bringing it back to prominence by 2030, according to GlobalData, […]
Precision medicine transforms healthcare beyond oncology, says GlobalData
Precision medicine is reshaping healthcare beyond its traditional focus on oncology. This innovative approach tailors medical treatments to individual genetic, environmental, and lifestyle factors, enhancing disease prevention, diagnosis, and treatment efficacy. From reproductive health advancements like biomarker screenings in IVF to pandemic preparedness initiatives, precision medicine is expanding its impact across diverse medical fields, promising […]
AI-augmented robotics to elevate Industry 4.0, says GlobalData
The integration of advanced robotics and artificial intelligence (AI) is transforming several industries such as manufacturing, healthcare, automotive, and aerospace and forging a path towards the realization of Industry 4.0. While companies are heavily investing in proprietary technologies for innovation and productivity, challenges like cybersecurity and high costs remain. Collaborative R&D efforts and standardized policies […]
EMA approval of Sanofi/Regeneron’s Dupixent fills biologic gap in COPD, says GlobalData
Following the European Medicines Agency (EMA) approval of Sanofi/Regeneron’s Dupixent (Dupilumab) on 03 July 2024: Asiyah Nawab, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view: “Dupixent, a monoclonal antibody (mAb) targeting interleukin-4 (IL4) and interleukin-13 (IL13) pathways, has been approved by the EMA as the first biologic for uncontrolled chronic […]
Canada card payments market to grow by 7.7% in 2024, forecasts GlobalData
Canada’s card payments market is forecast to grow by 7.7% in 2024 to reach CAD1.2 trillion ($913 billion), supported by high consumer preference for electronic payments, according to GlobalData, a leading data and analytics company. GlobalData’s Payment Cards Analytics reveals that card payment value in Canada registered a growth of 14.4% in 2022, driven by […]
Companion diagnostics drive precision oncology growth and accessibility, says GlobalData
Companion diagnostic (CDx) tests play a pivotal role in modern oncology by identifying specific biomarkers that guide personalized cancer treatments. These tests, such as HER2 testing in breast cancer, determine eligibility for targeted therapies like trastuzumab. The evolving landscape of CDx tests is marked by decreasing costs, driven by technological advancements and economies of scale, […]
Medical tourism gains prominence in filing documents of companies, finds GlobalData
Medical tourism has been gaining momentum and it is also evident from companies’ discussions that it presents a big opportunity. An in-depth analysis of the filing documents reveals that companies are focusing on the needs of international patients, including access to skilled healthcare professionals, advanced treatments, and world-class facilities, reveals the Company Filing Analytics Database […]
Volkswagen’s $5 billion bet on Rivian gets influencer attention on X, reveals GlobalData
Volkswagen (VW) and US-based electric vehicle (EV) startup Rivian Automotive have emerged as trending companies among the influencers on social media platform “X,” following the German automaker’s announcement of a strategic investment of up to $5 billion in Rivian. This partnership is perceived as mutually beneficial wherein Volkswagen secures access to Rivian’s advanced software-defined vehicle […]
Preventable injuries pose growing burden on Canada healthcare system, warns GlobalData
Injuries impose a significant emotional, physical, and economic burden on Canada. Nearly 4.8 million trauma and 58,000 burn injuries are expected in 2024, reflecting a 2% annual increase since 2018. These and other preventable injuries account for a large proportion of wound care spending in Canada – resources that could be redirected to improve mental […]
Humanoid robotics conversations surge 80% on social media platform X during H1 2024, reveals GlobalData
The field of humanoid robotics is evolving rapidly, merging sophisticated AI with precise mechanics to create robots that closely emulate human behaviors. Influencers on social media platform “X” are actively discussing on how these technological advancements could transform various sectors, which led to 80% rise in conversations during the first half (H1) of 2024 (January-June). […]